Technetium-99m-labeled ceftizoxime loaded long-circulating and pH-sensitive liposomes used to identify osteomyelitis

Soraya Maria Zandim Maciel Dias Ferreira1, Giselle Pires Domingos, Diego dos Santos Ferreira

  • 1Faculdade de Farmácia, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, 31270-901, Belo Horizonte, Minas Gerais, Brazil.

Insights

New liposomes carrying a technetium-99m-labeled antibiotic show promise for diagnosing bone infections like osteomyelitis. These specialized liposomes accumulate in infected areas, aiding in accurate detection.

Area of Science:

  • Nuclear medicine
  • Biomedical engineering
  • Infectious diseases

Background:

  • Osteomyelitis is a challenging bone infection requiring accurate diagnostic tools.
  • Current diagnostic methods may have limitations in sensitivity and specificity.

Purpose of the Study:

  • To develop and evaluate novel long-circulating and pH-sensitive liposomes labeled with technetium-99m and ceftizoxime (SpHL-(99m)Tc-CF).
  • To assess the potential of SpHL-(99m)Tc-CF for the diagnosis of osteomyelitis foci.

Main Methods:

  • Development of long-circulating, pH-sensitive liposomes encapsulating ceftizoxime.
  • Radiolabeling of liposomes with technetium-99m.
  • Biodistribution studies and scintigraphic imaging in rats with and without bone infection.

Main Results:

  • SpHL-(99m)Tc-CF demonstrated high accumulation in infectious foci.
  • High target-to-non-target ratios were observed in infected areas.
  • Scintigraphic images clearly visualized the bone infection sites.

Conclusions:

  • SpHL-(99m)Tc-CF shows significant potential as an imaging agent for diagnosing osteomyelitis.
  • The developed liposomal formulation enhances diagnostic capabilities for bone infections.

Related Concept Videos